Home Tags Inozyme Pharma Secures Flexible Debt Facility for up to $70 Million with K2 HealthVentures

Tag: Inozyme Pharma Secures Flexible Debt Facility for up to $70 Million with K2 HealthVentures

Inozyme Pharma Secures Flexible Debt Facility for up to $70 Million...

0
BOSTON, July 26, 2022 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment...
0FansLike
3,441FollowersFollow
0SubscribersSubscribe

EDITOR PICKS

SUBSCRIBE TO OUR NEWSLETTER

Get our latest downloads and information first. Complete the form below to subscribe to our weekly newsletter.